Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Current Opinion in Rheumatology|November 1, 1995
Clinical aspects of systemic and localized sclerodermaF H van den Hoogen, E M de JongJournal of the American Academy of Dermatology|August 15, 1998
Low-dose methotrexate in the treatment of widespread morpheaM M Seyger, F H van den Hoogen, T de Boo, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|October 6, 1999
Systemic sclerosis: new insights in autoimmunityS E Kaal, F H van Den Hoogen, E M de Jong, et al.The Journal of Pathology|March 29, 2001
Localized and systemic scleroderma show different histological responses to methotrexate therapyM M Seyger, F H van den Hoogen, I M van Vlijmen-Willems, et al.Current Opinion in Rheumatology|November 1, 1994
Treatment of systemic sclerosisF H van den Hoogen, L B van de PutteActa Dermato-Venereologica|October 21, 1998
Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosusM M Seyger, M C van Bruggen, H K Hardeman, et al.Clinical Rheumatology|September 1, 1990
Effects of immunomodulating therapy in systemic sclerosisF H van den Hoogen, A M Boerbooms, L B van de PutteArthritis and Rheumatism|April 1, 1991
The mutations in the fibronectin gene described in Japanese patients with systemic sclerosis are not present in Dutch patientsR Verheijen, E H Oberyé, F H van den Hoogen, et al.Clinical and Experimental Rheumatology|August 2, 2003
Assessment of skin, joint, tendon and muscle involvementA Akesson, G Fiori, T Krieg, et al.Annals of the Rheumatic Diseases|April 17, 2001
Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumour necrosis factor alpha blocking treatmentA A den Broeder, F H van den Hoogen, L B van de PuttePageof 14